Business news

Cyclic innovation to drive the Saliva-based Screening Market

Pocket-Friendliness coupled with Convenience to catalyze the Saliva-based Screening Market

Saliva has turned out to be as a brilliant replacement of serum-based testing since the last few years as it’s easier to collect and has a non-invasive nature. Plus, prevalence of biomarkers like genetic materials has proven to be revolutionary in the identification of systemic and oral illness. Also, considering the large population, saliva proves to be a cost-effective approach on the count of screening. Persistence Market Research has walked through the latest happenings in this regard through its market study stated below.

How does the Saliva-based Screening market disperse?

The global saliva-based screening market, by product, spans saliva collection kits, saliva nucleic acid purification kits, saliva-based detection kits (PCR-based tests and Rapid Tests). Purpose-wise, it’s diagnostics and research use. By application, it’s infection analysis/detection (non-Covid), genomic analysis, proteomics, pharmacogenomics and liquid biopsy. End-user-wise, it’s diagnostic laboratories, clinics & hospitals, academic and research institutes, and biopharmaceuticals and CROs. Persistence Market Research has brought in these details with insights in its latest market study entitled “Saliva-based Screening Market”.

Region-wise Sneak Peek

North America holds the largest market share due to an excessive demand for home-based/self-testing saliva-based screening in the US. Coming to Europe, Germany rules the roost. This could be attributed to granting of approvals to numerous key participants by EMA (European Medicines Agency) to promote their saliva-based screening tests therein. However, the Asia-Pacific is bound to reach the highest pedestal in the upcoming period with the highly populated regions being in dire need of saliva-based screening along with increasing awareness regarding the same. Persistence Market Research has entailed these in its market study entitled “Saliva-based Screening Market”.

Get To Know More –

The Key Competitors

Persistence market Research has profiled the key players in saliva-based screening market as Thermo Fisher Scientific, Hologic, Qiagen, Zymo Research Corporation, DNA Genotek Inc., Invitek Molecular GmbH, Salimetrics, LLC, BioChain Institute Inc., Mawi DNA Technologies LLC, Cell Projects Ltd., Kyodo International, Inc., Spectrum Solutions, NEOGEN Corporation, Xiamen Zeesan Biotech Co., Ltd., Sedia Biosciences Corporation, Biosynex SA, Chembio Diagnostics, Inc., Creative Diagnostics, and OraSure Technologies.

Persistence Market Research has gone ahead with mentioning the courses of development. For instance – OraSure Technologies, in January 2021, did launch Oragene Dx (OGD-610). It comes across as a device to collect saliva. Additionally, Salimetrics, in January 2020, brought forth a novel Salivary Human Total Immunoglobulin G (IgG) ELISA kit for supporting multidisciplinary investigators in the serological studies. Coming to inorganic mode of growth, Abbott Laboratories, in October 2017, did acquire Alere, Inc. to spread its wings in various other geographies.

Saliva-based screening market is slated to grow manifold between 2021 and 2031 – Persistence Market Research

To Top

Pin It on Pinterest

Share This